Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...
A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...
Axios Science on MSN21d
Mass. files suit accusing insulin makers of price-gougingMassachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...
Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...
Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
The Associated Press on MSN21d
Newsom Committed California to Making Its Own Insulin. It’s at Least a Year Behind His ScheduleGov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind schedule ...
As insulin prices in the United States continue to rise, making it increasingly difficult for diabetic patients to afford ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback